HCW Biologics (HCWB) Short Interest Ratio & Short Volume → This military-backed stock “owns” AI market (From Porter & Company) (Ad) Free HCWB Stock Alerts $1.09 0.00 (0.00%) (As of 05/31/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends HCW Biologics Short Interest DataCurrent Short Interest1,300 sharesPrevious Short Interest8,600 sharesChange Vs. Previous Month-84.88%Dollar Volume Sold Short$1,508.00Short Interest Ratio0.1 Days to CoverLast Record DateMay 15, 2024Outstanding Shares37,820,000 sharesFloat Size17,850,000 sharesShort Percent of Float0.01%Today's Trading Volume4,429 sharesAverage Trading Volume25,089 sharesToday's Volume Vs. Average18% Short Selling HCW Biologics ? Sign up to receive the latest short interest report for HCW Biologics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartHCWB Short Interest Over TimeHCWB Days to Cover Over TimeHCWB Percentage of Float Shorted Over Time Ad Porter & CompanyThis military-backed stock “owns” AI marketThe AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. HCW Biologics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20241,300 shares $1,508.00 -84.9%0.0%0.1 $1.16 4/30/20248,600 shares $12,040.00 +13.2%0.1%0.5 $1.40 4/15/20247,600 shares $12,312.00 -52.2%0.1%0.5 $1.62 3/31/202415,900 shares $27,825.00 -27.7%0.1%1 $1.75 3/15/202422,000 shares $33,660.00 -8.3%0.1%1.3 $1.53 2/29/202424,000 shares $35,280.00 +445.5%0.2%1.7 $1.47 Get the Latest News and Ratings for HCWB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for HCW Biologics and its competitors with MarketBeat's FREE daily newsletter. 2/15/20244,400 shares $5,030.08 +2.3%0.0%0.4 $1.14 1/31/20244,300 shares $4,945.00 -39.4%0.0%0.2 $1.15 1/15/20247,100 shares $8,378.00 -4.1%0.0%0.4 $1.18 12/31/20237,400 shares $9,065.00 -38.8%0.0%0.4 $1.23 12/15/202312,100 shares $13,431.00 -40.7%0.1%0.8 $1.11 11/30/202320,400 shares $22,032.00 -4.7%0.1%1.4 $1.08 11/15/202321,400 shares $19,688.00 +170.9%0.1%1.6 $0.92 10/31/20237,900 shares $13,272.00 -16.8%0.0%0.6 $1.68 10/15/20239,500 shares $17,290.00 -10.4%0.1%1.3 $1.82 9/30/202310,600 shares $20,140.00 -53.1%0.1%1.3 $1.90 9/15/202322,600 shares $45,426.00 +5.6%0.1%2.5 $2.01 8/31/202321,400 shares $38,734.00 -14.4%0.1%1.9 $1.81 8/15/202325,000 shares $52,000.00 +7.8%0.1%1.4 $2.08 7/31/202323,200 shares $47,328.00 -13.4%0.1%1.2 $2.04 7/15/202326,800 shares $56,816.00 -23.7%0.2%1.4 $2.12 6/30/202335,100 shares $76,167.00 +44.4%0.2%1.8 $2.17 6/15/202324,300 shares $51,759.00 +86.9%0.1%1.2 $2.13 5/31/202313,000 shares $19,110.00 -13.3%0.1%0.7 $1.47 5/15/202315,000 shares $22,051.50 -45.3%0.1%1 $1.47 4/30/202327,400 shares $39,146.38 -0.7%0.2%1.8 $1.43 4/15/202327,600 shares $41,400.00 +10.8%0.2%1.5 $1.50 3/31/202324,900 shares $34,884.90 +11.7%0.1%1.2 $1.40 3/15/202322,300 shares $30,105.00 -20.6%0.1%1 $1.35 2/28/202328,100 shares $50,580.00 +53.6%0.2%1.3 $1.80 2/15/202318,300 shares $34,587.00 +140.8%0.1%0.8 $1.89 1/31/20237,600 shares $14,744.00 -68.3%0.0%0.4 $1.94 1/15/202324,000 shares $51,600.00 +31.2%0.2%1.2 $2.15 12/30/202218,300 shares $35,040.84 +19.6%0.1%1.1 $1.91 12/15/202215,300 shares $30,600.00 -41.6%0.1%0.8 $2.00 11/30/202226,200 shares $55,302.96 +84.5%0.2%1.2 $2.11 11/15/202214,200 shares $31,240.00 +23.5%0.1%0.6 $2.20 10/31/202211,500 shares $25,760.00 -45.2%0.1%0.5 $2.24 10/15/202221,000 shares $46,830.00 -58.7%0.1%0.9 $2.23 9/30/202250,900 shares $116,561.00 +216.2%0.3%2.4 $2.29Kiss of death from Joe Biden (Ad)I did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but Biden does not care.I have uncovered a bombshell that changes everything… and threatens everything. 9/15/202216,100 shares $39,284.00 +35.3%0.1%0.9 $2.44 8/31/202211,900 shares $30,542.54 -7.8%0.1%0.7 $2.57 8/15/202212,900 shares $28,767.00 -30.7%0.1%1 $2.23 7/31/202218,600 shares $44,454.00 +78.9%0.1%1.4 $2.39 7/15/202210,400 shares $24,232.00 -38.1%0.1%0.8 $2.33 6/30/202216,800 shares $36,960.00 +24.4%0.1%0.9 $2.20 6/15/202213,500 shares $32,265.00 -9.4%0.1%0.5 $2.39 5/31/202214,900 shares $30,992.00 -54.6%0.1%0.5 $2.08 5/15/202232,800 shares $64,616.00 +9.0%0.2%1.1 $1.97 4/30/202230,100 shares $70,434.00 -32.5%0.2%0.9 $2.34 4/15/202244,600 shares $121,312.00 -3.5%0.3%0.9 $2.72 3/31/202246,200 shares $126,126.00 -11.0%0.3%0.7 $2.73 3/15/202251,900 shares $106,914.00 +19.6%0.4%0.6 $2.06 2/28/202243,400 shares $95,046.00 -32.4%0.3%0.4 $2.19 2/15/202264,200 shares $150,870.00 -18.5%0.5%0.6 $2.35 1/31/202278,800 shares $168,632.00 -39.3%0.6%0.5 $2.14 1/15/2022129,800 shares $288,156.00 +5.3%1.1%0 $2.22 12/31/2021123,300 shares $286,056.00 +35.5%1.0%0 $2.32 12/15/202191,000 shares $249,340.00 -3.1%0.7%0 $2.74 11/30/202193,900 shares $269,493.00 -0.2%0.8%0 $2.87 11/15/202194,100 shares $278,536.00 -39.5%0.8%0 $2.96 10/29/2021155,400 shares $694,638.00 +60.0%1.3%0.1 $4.47 10/15/202197,100 shares $254,402.00 No Change0.8%0.6 $2.62 9/30/202197,100 shares $309,749.00 +13.0%0.8%0.7 $3.19 9/15/202185,900 shares $325,561.00 +30.2%0.7%0.6 $3.79 8/31/202166,000 shares $262,020.00 +1,366.7%0.8%0.4 $3.97 8/13/20214,500 shares $23,040.00 No Change0.1%0 $5.12 HCWB Short Interest - Frequently Asked Questions What is HCW Biologics' current short interest? Short interest is the volume of HCW Biologics shares that have been sold short but have not yet been closed out or covered. As of May 15th, investors have sold 1,300 shares of HCWB short. 0.01% of HCW Biologics' shares are currently sold short. Learn More on HCW Biologics' current short interest. What is a good short interest percentage for HCW Biologics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.01% of HCW Biologics' floating shares are currently sold short. Is HCW Biologics' short interest increasing or decreasing? HCW Biologics saw a decrease in short interest in May. As of May 15th, there was short interest totaling 1,300 shares, a decrease of 84.9% from the previous total of 8,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is HCW Biologics' float size? HCW Biologics currently has issued a total of 37,820,000 shares. Some of HCW Biologics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. HCW Biologics currently has a public float of 17,850,000 shares. How does HCW Biologics' short interest compare to its competitors? 0.01% of HCW Biologics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to HCW Biologics: T2 Biosystems, Inc. (22.49%), Enlivex Therapeutics Ltd. (1.10%), Alimera Sciences, Inc. (0.20%), Rigel Pharmaceuticals, Inc. (3.22%), Veru Inc. (8.65%), Sagimet Biosciences Inc. (10.29%), Context Therapeutics Inc. (1.38%), Cartesian Therapeutics, Inc. (13.69%), ProQR Therapeutics (0.45%), InterCure Ltd. (0.26%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short HCW Biologics stock? Short selling HCWB is an investing strategy that aims to generate trading profit from HCW Biologics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against HCW Biologics? A short squeeze for HCW Biologics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HCWB, which in turn drives the price of the stock up even further. How often is HCW Biologics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HCWB, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: T2 Biosystems Short Squeeze Enlivex Therapeutics Short Squeeze Alimera Sciences Short Squeeze Rigel Pharmaceuticals Short Squeeze Veru Short Squeeze Sagimet Biosciences Short Squeeze Context Therapeutics Short Squeeze Cartesian Therapeutics Short Squeeze ProQR Therapeutics Short Squeeze InterCure Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:HCWB) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBiden Nomination CANCELED?The Freeport SocietyTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBuy this small stock before coming AI Tidal WaveChaikin AnalyticsWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HCW Biologics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.